Browse allCohortiasCRO · MexicoFeasibility and site selection, clinical development services and regulatory affairs.Request a quoteAsk about this companyWebsite (opens in a new tab)What they doClinicalFeasibility and site selectionClinical development servicesClinical monitoringPharmacovigilanceClinical data managementPatient recruitmentStudy start-upPhase I clinical unitRegulatory & qualityRegulatory affairsQuality assurance and auditingFrom their websiteServicesEarly Phase Trials (opens in a new tab)Phase II & III trials (opens in a new tab)Rescue studies (opens in a new tab)Medical devices (opens in a new tab)Project management (opens in a new tab)Site selection & training (opens in a new tab)Investigator meetings (opens in a new tab)Company websiteProtocol development (opens in a new tab)Site contracting (opens in a new tab)Interventional programs (opens in a new tab)Observational programs (opens in a new tab)Pilot device studies (opens in a new tab)Pivotal device studies (opens in a new tab)Early phase trialsDose-escalation arm (opens in a new tab)Early Phase Trials Platform (opens in a new tab)Phase 2 3 trials latinamericaDouble-blind outcomes trial (opens in a new tab)PPAR agonist (opens in a new tab)PCSK9 inhibitor (opens in a new tab)Query resolution (opens in a new tab)Our sciencePeer-to-peer model (opens in a new tab)Show all (23)Our scienceFDA-standard sites (opens in a new tab)Company websiteFour-country regulatory coverage (opens in a new tab)Phase 2 3 trials latinamericaSponsor systems (opens in a new tab)Quality & certificationsGCP (opens in a new tab)FDA requirements (opens in a new tab)Cofepris (opens in a new tab)ANMAT (opens in a new tab)ANVISA certified (opens in a new tab)INVIMA (opens in a new tab)